Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 164,986 | 176,346 | 212,382 | 169,647 | 117,324 |
| Marketable Securities | 816,544 | 585,835 | 662,270 | 321,254 | 446,032 |
| Receivables | 75,000 | N/A | N/A | N/A | N/A |
| Other current assets | 0 | 0 | 0 | 70,000 | 0 |
| TOTAL | $1,081,270 | $784,744 | $894,233 | $571,913 | $578,750 |
| Non-Current Assets | |||||
| PPE Net | 2,765 | 1,130 | 1,228 | 1,125 | 1,091 |
| Intangibles | 10,000 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 3,198 | 3,143 | 3,957 | 4,100 | 2,483 |
| TOTAL | $15,963 | $4,273 | $5,185 | $5,225 | $3,574 |
| Total Assets | $1,097,233 | $789,017 | $899,418 | $577,138 | $582,324 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 8,435 |
| Accounts payable and accrued liabilities | 8,652 | 13,313 | 8,683 | 10,063 | 8,518 |
| Accrued Expenses | 55,142 | 38,492 | 62,013 | 40,633 | 35,344 |
| TOTAL | $63,794 | $51,805 | $70,696 | $50,696 | $52,585 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 50,436 | 49,940 | 20,890 | 12,353 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 288 |
| Other Non-Current Liabilities | 371,342 | 50,768 | 56,615 | 2,582 | 2,077 |
| TOTAL | $371,342 | $101,204 | $106,555 | $23,472 | $14,570 |
| Total Liabilities | $435,136 | $153,009 | $177,251 | $74,168 | $67,155 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 113,292 | 103,075 | 102,207 | 95,442 | 81,662 |
| Common Shares | 1,132 | 1,025 | 1,018 | 822 | 817 |
| Retained earnings | -1,570,478 | -1,443,359 | -1,338,458 | -1,218,103 | -1,183,504 |
| Other shareholders' equity | 96,871 | 131,498 | 132,503 | 189,248 | 188,954 |
| TOTAL | $662,097 | $636,008 | $722,167 | $502,970 | $515,169 |
| Total Liabilities And Equity | $1,097,233 | $789,017 | $899,418 | $577,138 | $582,324 |